PURPOSE: To determine the efficacy of intravitreal @entity2995 (ivTA) injection in the management of @entity1103 ( @entity1103 ) due to @entity1596 in @entity1 with @entity195 . METHODS: Ten eyes of seven @entity1 with @entity1103 associated with @entity195 were included in the study. A quantity of 4 mg of @entity2995 was injected intravitreally in all of the eyes. The maculas of the @entity1 were evaluated with optical coherence tomography (OCT) and @entity941 angiography (FA). The change in visual acuity, @entity941 leakage, macular thickness, and potential complications were assessed. RESULTS: The mean follow-up was 15.6 months (range 7-19 months). There was an increase of more than two Snellen lines in the visual acuity in seven of the ten eyes (70%) at the last examination. Macular @entity4 regressed completely in eight of the ten eyes (80%) at the last visit on OCT and FA. The mean central macular thickness assessed by OCT @entity36051 mum before treatment and 186.9 mum at the last visit. The intraocular pressure (IOP) exceeded 21 mmHg in six eyes of five @entity1 (60%) during the follow-up. At the last visit, the IOP was less than 21 mmHg in five eyes with medication. One eye underwent @entity726 filtration surgery. Four eyes of three @entity1 had @entity231 progression. In four eyes of four @entity1 (40%), a second ivTA injection was given due to relapsing @entity1103 . CONCLUSION: Intravitreal @entity2995 (ivTA) may be beneficial in the management of @entity1103 in @entity1 with @entity195 . Repeated ivTA injections might be required if @entity1103 reoccurs.

Intravitreal XXXX in the management of @entity1103 in @entity195 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2995 :: ('MESH:D014222', 'Chemical') :: ['triamcinolone acetonide'] @entity231 :: ('MESH:D002386', 'Disease') :: ['cataract'] @entity4 :: ('MESH:D004487', 'Disease') :: ['edema'] @entity1596 :: ('MESH:D014605', 'Disease') :: ['uveitis'] @entity726 :: ('MESH:D005901', 'Disease') :: ['glaucoma'] @entity1103 :: ('MESH:D008269', 'Disease') :: ['CME', 'cystoid macular edema'] @entity941 :: ('MESH:D019793', 'Chemical') :: ['fluorescein'] @entity195 :: ('MESH:D000544', 'Disease') :: ["Beh  et's disease"] @entity36051 :: ('MESH:C525125', 'Chemical') :: ['was 406']
@entity2995 :: (MESH:D014222,Chemical) :: ['triamcinolone acetonide']
